Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Synthorx

- PMLiVE

Sanofi picks corporate voice for new blogging venture

Pharma company's US arm goes beyond discussing diabetes

- PMLiVE

Baxter expands kidney disease business with $4bn Gambro deal

Strengthens haemodialysis portfolio with purchase of Swedish medical tech firm

- PMLiVE

Sanofi takes anti-counterfeiting message to the skies

Hopes to reach four million passengers with Air France film

Sanofi reception

Sanofi signs $900m allergy collaboration with Selecta

Companies will develop three immunotherapies targeting different allergens

Kala Pharma appoints Fovea founder Bernard Gilly to board

He previously formed the company that became Sanofi’s ophthalmology business

- PMLiVE

GSK raises stake in Nigerian unit

Set to expand in growing market

- PMLiVE

Reckitt beats Bayer to acquire nutrition company Schiff

Provides springboard to US consumer health market

Sanofi reception

Sanofi’s Lyxumia and Zaltrap backed for European approval

Company on course to expand its diabetes and cancer portfolio

- PMLiVE

Sanofi and T1D Exchange collaborate to understand needs of children living with diabetes

Aims to deliver recommendations for better disease management and patient outcomes

Pharma deals during October 2012

As pharma companies ramp up their activity after the summer, this month's dealmakers included Pfizer, AstraZeneca, Merck & Co and Bayer

Sanofi’s Christopher Viehbacher to take the reins at EFPIA

Will serve as European pharma body's president from next June

- PMLiVE

Bayer makes $1.2bn bid for Schiff Nutrition, reports Q3

Boosts consumer health division as group sales climb 11.5 per cent

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links